Human fetal testis xenografts are resistant to phthalate-induced endocrine disruption

Nicholas E Heger1, Susan J Hall, Moses A Sandrof

  • 1Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA.

Abstract

Insights

Phthalate exposure alters fetal germ cells in human testes but does not suppress testosterone production. This study developed a new bioassay to assess human fetal testis response to endocrine disruptors.

Area of Science:

  • Reproductive toxicology
  • Endocrinology
  • Developmental biology

Background:

  • In utero exposure to endocrine-disrupting chemicals like phthalates may cause testicular dysgenesis syndrome (TDS) in males.
  • Phthalates induce multinucleated germ cells (MNG) and suppress testosterone production in fetal rat testes, but only MNG in mice, indicating species-specific sensitivity.
  • Existing methods like ex vivo exposure do not fully replicate in vivo endocrine disruption, necessitating a new bioassay for human fetal testis response.

Purpose of the Study:

  • To develop and validate a rat and mouse testis xenograft bioassay for phthalate exposure.
  • To assess the response of human fetal testes to phthalate exposure using this novel bioassay.

Main Methods:

  • Fetal rat, mouse, and human testes were xenografted into immunodeficient rodents.
  • Hosts received multiple daily doses of phthalates.
  • Xenografts were analyzed for histopathology and steroidogenic gene expression.

Main Results:

  • Phthalate exposure induced MNG formation in rat and mouse xenografts, mirroring in utero findings.
  • Steroidogenesis was suppressed in rat xenografts but not in mouse xenografts.
  • Human fetal testis xenografts showed MNG induction but were resistant to suppressed steroidogenic gene expression.

Conclusions:

  • The xenograft model confirmed species-specific responses to phthalates.
  • Human fetal testes xenografts demonstrated altered fetal germ cells but maintained testosterone biosynthesis gene expression.
  • This bioassay provides a new tool to evaluate endocrine disruptor effects on the human fetal testis.